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Abstract
Background: The understanding of the influence of smoking and sex on lung function and symptoms is
important for understanding diseases such as COPD. The influence of both genes and environment on lung
function, smoking behaviour and the presence of respiratory symptoms has previously been demonstrated for
each of these separately. Hence, smoking can influence lung function by co-varying not only as an environmental
factor, but also by shared genetic pathways. Therefore, the objective was to evaluate heritability for different
aspects of lung function, and to investigate how the estimates are affected by adjustments for smoking and
respiratory symptoms.
Methods: The current study is based on a selected sample of adult twins from the Swedish Twin Registry. Pairs
were selected based on background data on smoking and respiratory symptoms collected by telephone interview.
Lung function was measured as FEV1, VC and DLco. Pack years were quantified, and quantitative genetic analysis
was performed on lung function data adjusting stepwise for sex, pack years and respiratory symptoms.
Results: Fully adjusted heritability for VC was 59% and did not differ by sex, with smoking and symptoms
explaining only a small part of the total variance. Heritabilities for FEV1 and DLco were sex specific. Fully adjusted
estimates were10 and 15% in men and 46% and 39% in women, respectively. Adjustment for smoking and
respiratory symptoms altered the estimates differently in men and women. For FEV1 and DLco, the variance
explained by smoking and symptoms was larger in men. Further, smoking and symptoms explained genetic
variance in women, but was primarily associated with shared environmental effects in men.
Conclusion: Differences between men and women were found in how smoking and symptoms influence the
variation in lung function. Pulmonary gas transfer variation related to the menstrual cycle has been shown before,
and the findings regarding DLco in the present study indicates gender specific environmental susceptibility not
shown before. As a consequence the results suggest that patients with lung diseases such as COPD could benefit
from interventions that are sex specific.
Introduction
The adult individuals’ lung function is determined both
by the maximal level of lung function growth achieved
during childhood and adolescence, and by the rate of
decline that follows from the early twenties onwards.
Both these are likely to be of importance for later devel-
opment of respiratory disease, such as COPD. Further-
m o r e ,f a c t o r sa sF E V 1, and VC are powerful predictors
of mortality [1,2].
In healthy populations, level of lung function is
strongly genetically determined both early and later in
life, for both men and women [3-6]. Lung function will
also be affected by, or co-vary, with other factors, such
as smoking and chronic respiratory diseases. However,
the relationships between these variables are not always
obvious as some smokers never develop symptoms and
lung function decline, while some never smokers
become ill, etc [1,2]. Interestingly, as smoking behaviour
in itself is determined both by genes and environment,
it can influence lung function by co-varying not only as
an environmental factor, but also by shared genetic
pathways [3,7]. Further, both respiratory symptoms and
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co-variance with pulmonary function measures [8,9].
This has brought to attention the possibility that an
individual’s genes affect his or her sensitivity to factors
important for respiratory health [3].
Therefore, the objective of the current cross-sectional
study in a Swedish sample of twins was to evaluate her-
itability for different measures of lung function, and to
investigate, by sex, how the estimates are affected by the
covariates smoking and respiratory symptoms.
Materials and methods
Study population
The current study (approved by the Ethical Committee
at Karolinska Institute, # 03-461) is based on a selected
sample of twins born 1926-1958 from the population
based Swedish Twin Registry [10,11] who were con-
tacted using a computer-assisted telephone interview in
1998-2002. The interview included a checklist of com-
mon diseases and respiratory symptoms, as well as
smoking habits [10,11]. Details are shown in the online
appendix. From the population of 26,516 twins in pairs
where both participated in the telephone interview,
1,030 twins in 515 pairs were selected to participate in
more in-depth measures of lung function. The subjects
gave written informed consent to participate in the
study. To assure that the sample would contain twins
with symptoms of respiratory disease (self-reported
symptoms of cough, chronic bronchitis, emphysema or
asthma) disease concordant and discordant twins were
prioritized over symptom free twin pairs. Due to the
relatively small number of symptom concordant twins
available in the population, pairs were included regard-
less of smoking habits, while symptom discordant and
symptom free pairs were further stratified according to
whether none, one, or both of the twins in a pair had a
s i g n i f i c a n ts m o k i n gh i s t o r y ,i . e .h a ds m o k e dm o r e
than 10 pack years (1 pack year is equal to smoking 20
cigarettes per day for 1 year) at the time of inclusion.
Table 1 describes the number of twins with the specified
combinations of symptoms/smoking habits available
from the Swedish Twin Registry. In order to reach the
desired number of twin pairs in each category, it was
necessary to invite twins from the whole country, as
well as twins over a relatively large age span (from 50
yrs with no upper limit), to the study hospital, situated
in Stockholm, Sweden. In total, 392 twins (38%) of
1,030 twins accepted the invitation to participate. Two
of the 392 twins participated only by sending in the
questionnaire due to poor health. Technically acceptable
forced expiratory volume in one second (FEV1) and vital
capacity (VC) measurements were performed by 378
individuals, resulting in 181 complete pairs. Five indivi-
duals had incomplete information on smoking habits,
resulting in 176 complete twin pairs available for covari-
a t ea n a l y s i s .T h ec o r r e s p o n ding figures for acceptable
single breath carbon monoxide diffusing capacity (DLco)
measurements were 375 individuals in 178 complete
twin pairs. After excluding those with missing smoking
data, 173 complete pairs remained.
Lung function testing
All lung function tests were carried out in a single specia-
lized clinic with highly experienced staff. Lung function
in terms of FEV1, VC and DLco was measured according
to American Thoracic Society criteria [12,13], using a
Sensormedics 6200 body plethysmograph (SensorMedics;
Yorba Linda, CA, USA). Each subject performed several
slow and forced vital capacity expirations. FEV1 was
compared to the largest obtained VC and individuals
with an obstructive pattern (an FEV1/VC ratio 5 units
below the predicted value, or FEV1 below 90% of the pre-
dicted value) also performed a new test 15 minutes after
bronchodilation with a short-acting beta2-agonist (nebu-
lized Salbutamol). The maximum values for VC and
FEV1 (measured pre- or post bronchodilation) were then
used for analysis. Based on lung function, twins could be
classified according to GOLD-criteria [14].
Self reported cigarette smoking was assessed at the
clinical examination and quantified as pack years.
Determination of twin zygosity
Zygosity of the sex-liked pairs was determined by the
u s eo fas e to fD N Am a r k e r sf r o mb l o o dd r a w na tt h e
clinical testing. Blood samples were not available for
both members in 14 pairs, and zygosity information for
these twins was instead obtained at the time of registry
compilation on the basis of questions about childhood
resemblance. Four separate validation studies using ser-
ology and/or genotyping have shown that with these
questions 95-98% of twin pairs are classified correctly
[11].
Table 1 Available, invited and participating twins from
the Swedish Twin Registry.
Group 1 2 3 4 5 6 Total
Symptoms: twin1, twin2 ++ –– – -+ -+
Smoking > 10 PY:
twin1, twin2
– -+ ++ – ++
No of available 834 12,008 7,708 4,158 1,050 758 26,516
No of invited 394 128 164 106 86 152 1,030
No of participating 130 56 79 43 42 42 392
Participation in % of
available
15.6 0.5 1.0 1.0 4.0 5.5 1.5
Groups: 1) Both have respiratory or minor respiratory symptoms, 2) Both healthy,
neither have > 10 pack years, 3) Both healthy, one twin with > 10 pack years, 4)
Both healthy, both have > 10 pack years, 5) One twin with respiratory symptoms,
one healthy, neither have > 10 pack years, 6) One twin with respiratory
symptoms, one healthy, both have > 10 pack years,.
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Respiratory symptoms and pack years were assessed as
covariates in the linear multivariate regression models
stratified by sex. Analyses were performed with the
Stata 9.2 software package (StataCorp LP, College Sta-
tion, TX, USA)
Quantitative genetic analysis
Quantitative genetic analysis aims to provide estimates
of the importance of genes and environment for the var-
iation of a trait or disease (phenotype). The phenotypic
variance is assumed to be due to three latent, or unmea-
sured, factors: additive genetic factors (a
2), shared envir-
onmental factors (c
2) or dominant genetic factors (d
2),
and non-shared environmental factors (e
2), which also
include measurement error. Heritability is a term that
describes the proportion of total phenotypic variation
directly attributable to genetic effects [15]. Twins are
ideal for these types of studies as we know how they are
genetically related: identical (monozygotic (MZ)) twins
share the same genes, whereas fraternal (dizygotic (DZ))
twins share, on average, half of their segregating genes.
We also assume that shared environment (for example
the presence of a childhood cat, or parental socioeco-
nomic status) contributes to within-pair likeness to the
same extent in MZ and DZ twin pairs. By calculating
similarity within and between MZ and DZ twin pairs,
we can obtain information about the importance of
genetic and environmental factors to the variance of the
trait in question. One such measure of twin similarity is
the intra-class correlation (ICC) [16].
These assumptions can also be illustrated in a path
diagram, representing a mathematical model of how
genes and environment are expected to contribute to
phenotypic variance [11]. Figure 1 illustrates a path dia-
gram for an opposite-sex twin pair. The additive genetic
correlation (ra) is set to 1 in MZ twins and 0.5 in like-
sex DZ twins, based on how genetically related they are,
as described above. The shared environment correlation
(rc) is the same for MZ and DZ twins and therefore set
to 1 for both groups. By definition there is no correla-
tion for the non-shared environment. The additive
genetic, shared, and non-shared environmental variance
components are noted as am,c m,e m,a f,c f,a n de f,f o r
men and women, respectively. The dominant genetic
correlation, not included in this figure, is set to 1 in MZ
twins and 0.25 in like-sex DZ twins. The simultaneous
estimation of c
2 and d
2 is not possible because of statis-
tical issues [17]. However, which factor should be mod-
elled is suggested by the ICC, where d
2 is only included
in the model if the correlations of DZ twins are less
than half the correlations of MZ twins.
In order to test for sex differences, i.e. whether the same
genes and environment contribute to the phenotypic var-
iance in both men and women, different versions of the
models can be compared [18]. In the first variance model,
we allow the genetic and environmental variance compo-
nents to be different for men and women, and the genetic
correlation (ra) is free to be estimated for opposite-sexed
DZ twins. For instance, if the genetic correlation is esti-
mated at 0, it indicates that completely different genes
influence the trait in men and women. Variance model 2
tests whether the genetic and environmental variance com-
ponents are allowed to be different for women and men
(e.g. if genetic variance is more important in men than in
women), constraining the genetic correlation for members
Figure 1 Basic path diagram for an opposite sexed twin pair.A m,C m,E m,A f,C f,a n dE f are the genetic, shared and non-shared
environmental variance components for men and women, respectively. The genetic correlation, ra, is set free to be estimated in the model,
while the shared environmental correlation, rc, is set to 1.
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equal genetic and environmental variance components for
men and women. If the fit of this models is not signifi-
cantly different compared to the previous, we can assume
that there are no sex differences in the magnitude of
genetic and environmental influences. In summary, the dif-
ference in chi-squares between nested models is calculated
in order to test which of the models fits better. A signifi-
cant chi square difference indicates that the model with
fewer parameters to be estimated fits the data worse.
Model fitting was performed with the Mx program [19].
All models were tested using lung function in percent
of predicted value, the same adjusted for pack years, and
finally also adjusted for presence of respiratory
symptoms.
Results
Descriptive statistics
A summary of the available and participating twins is
presented in table 1.
Lung function results and covariates (age, height, pack-
years and symptoms) are presented by zygosity group in
table 2 and were found to influence independently and
significantly each lung function measure (p < 0.05).
GOLD stages for twins with lung function data were:
Stage 1 - 53 twins (15% of the cohort), stage 2 - 42 twins
(12%), stage 3 and above - 2 twins (1%).
Intraclass correlations
Intraclass correlations (ICC) for unadjusted and adjusted
lung function variables are presented in table 3. Compar-
ing ICC for MZ and DZ twins, the presence of additive
genetic influences (ICC for MZ twins > 2 × ICC for DZ
twins) was indicated for all measures, except for FEV1 in
men, where DZ twins showed similar or higher correlation
compared to MZ twins, indicating that additive genetic
influences are of less importance. For DLco in women,
MZ correlations were more than twice as high as DZ cor-
relations, showing evidence of genetic dominance. Sex
differences were also indicated for FEV1, as unlike sexed
DZ twins had lower ICC compared to same-sex DZ.
Sex differences in the genetic influence on measures of
lung function
In order to test for sex differences, structural equation
variance models with different assumptions regarding
the influence of genetic and environmental effects in
men and women were fitted based on the ICC results.
The models were then compared to each other to find
the most parsimonious one fitting our data. Specific var-
iance model fitting results are available in the online
appendix (table 4).
In summary, a model including additive genetic fac-
tors (A), shared environmental factors (C) and non-
shared environmental factors (E) was used for VC and
FEV1. The comparisons of variance models indicated
that the importance of genetic and environmental effects
was the same in men and women (figure 2). For FEV1,
the same genes are of importance for men and women
(comparing model 2 and 1 in table 5), but the influence
of genes and environment differs by sex (significantly
different fit between model 2 and 3).
For DLco, separate models had to be fitted from the
start for men and women. For men, a model containing
A, C and E was used (as above), while a model including
A, E and dominant genetic factors (D) was used for
women, since there was evidence for genetic dominance
in the latter group (table 6).
Contribution of genes and environment to the total
variance
Figure 3 shows the variance in absolute numbers (A + C +
E = absolute total variance), while figure 2 shows the
extent to which genetic and environmental factors con-
tributed to the total variance (%a
2 +% c
2 +% e
2 = 100% of
total variance).
Unadjusted data show that mainly genetic, but also
non-shared environmental influences were of impor-
tance for the variance of VC. For FEV1 and DLco, ana-
lyses had to be separated by sex, as indicated above. For
both measures, the variance was attributable to both
genetic and environmental factors for women, but only
to environmental factors in men (figure 2).
Table 2 Mean value (± Standard Deviation) for lung function measures and covariates, by sex and zygosity.
Men Women Opposite sexed pairs (n = 42)
MZ (n = 28) DZ(n = 14) MZ(n = 65) DZ(n = 27) Men Women
Age 60.5 ± 9.0 59.8 ± 7.3 59.1 ± 8.3 60.1 ± 9.6 58.5 ± 8.7 58.5 ± 8.8
Height 178.7 ± 5.7 180.1 ± 5.3 164.4 ± 6.2 163.9 ± 5.5 178.3 ± 5.5 165.0 ± 4.8
Pack yrs
1 11.6 ± 17.6 22.4 ± 20.2 9.5 ± 14.0 13.6 ± 16.9 15.5 ± 16.2 11.9 ± 16.5
VC in % pred. 100.64 ± 13.00 97.86 ± 15.83 111.99 ± 15.42 108.89 ± 13.94 101.97 ± 13.04 113.81 ± 14.90
FEV1 in % pred. 92.97 ± 14.91 89.70 ± 18.37 98.96 ± 16.60 98.21 ± 15.77 96.27 ± 15.53 102.68 ± 14.99
DLco
2 in % pred. 95.06 ± 18.44 92.45 ± 19.58 87.11 ± 16.08 79.97 ± 14.54 91.83 ± 18.99 89.33 ± 15.97
Multiple regression was used in order to test for differences in the mean levels of age, height, packyears and lung function measures (VC, FEV1 and DLco)
between the zygosity groups. Adjustment for sex was made for height and lung function measures.
1Packyears at examination.
2 n pairs MZ male = 28, DZ male
= 15, MZ female = 66, DZ female = 25, OS = 39.
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Adjustment for pack-years and respiratory symptoms
resulted in a decrease of the total variance of all lung func-
tion measures (VC, FEV1, and DLco) between 7 and 37%.
For VC, the decrease in total variance was due to a
small reduction of genetic variance, whilst the non-
shared environmental variance was stable after adjust-
ments. For FEV1 and DLco, the effect of smoking and
symptoms was found to be larger in men than in
women. The total variance decrease was due to a reduc-
tion attributed to genetic variance in women, and shared
environmental variance in men.
Discussion
In the current study all lung function measures (VC,
FEV1 and DLco) were shown to be influenced by genetic
factors. FEV1 a n dD L c os h o w e ds e xd i f f e r e n c e si nt h e
relative importance of genes and environment, as well
as in how smoking and respiratory symptoms influence
the genetic and environmental estimates of the trait.
Heritability of FEV1 has been studied before, but for the
gas transfer measure DLco, related to clinical findings
such as emphysema, the information is new. VC herit-
ability was higher, and without sex differences.
The relationship between smoking and the presence of
respiratory symptoms as well as impaired lung function
has been long known. More recently, studies of general
twin populations have suggested that genetic factors are
of importance in individual differences in lung function
[4,6,20], and family studies have shown that relatives of
subjects with COPD had a higher risk of airflow
o b s t r u c t i o nt h a nc o n t r o l s[ 2 1 - 2 3 ] .I na n o t h e rs t u d yo f
unselected elderly twins in the Swedish twin registry [6],
heritability estimates adjusted for smoking were lower
for FEV1 (24-41% vs. 67%) but more similar for VC
(61% vs. 48%) than the current results. In that study no
sex differences were found in heritability estimates, but
opposite sexed pairs were not included, reducing power
to find such differences. Heritability is population speci-
fic and will differ between samples that differ in the dis-
tribution of environmental risk factors. Even though
both populations were of the same nationality and age
range, the prevalence of smoking habits and symptoms
would have been lower in the unselected second mate-
rial, which could explain why differences between stu-
dies were seen particularly for FEV1,w h i c h ,a ss t a t e d
above, is known to be susceptible to these factors.
Table 3 Intraclass correlations (with 95% confidence intervals) for unadjusted and adjusted FEV1, VC and DLco in a
Swedish twin sample by sex and zygosity status.
Men Women OS
MZ (n = 28) DZ (n = 14) MZ (n = 65) DZ (n = 27) (n = 42)
VC
Unadjusted 0.57(0.26;0.78) 0.41(-0.16;0.77) 0.67(0.50;0.78) 0.18(-0.21;0.53) 0.23(-0.08;0.50)
Adj. PY 0.49(0.15;0.73) 0.29(-0.29;0.71) 0.67(0.50;0.78) 0.28(-0.12;0.59) 0.25(-0.06;0.52)
Adj. PY, symptoms 0.36(-0.01;0.65) 0.18(-0.39;0.65) 0.66(0.50;0.78) 0.26(-0.14;0.58) 0.24(-0.07;0.51)
FEV1
Unadjusted 0.28(-0.10;0.59) 0.42(-0.14;0.78) 0.67(0.50;0.78) 0.32(-0.07;0.62) -0.07(-0.37;0.24)
Adj. PY 0.27(-0.12;0.58) 0.25(-0.33;0.69) 0.66(0.50;0.78) 0.39(0.01;0.67) -0.01(-0.31;0.30)
Adj. PY, symptoms 0.18(0.21-0.52) 0.18(-0.39;0.65) 0.65(0.48;0.77) 0.32(-0.06;0.63) -0.09(-0.38;0.22)
DLCO
Unadjusted 0.58(0.27;0.79) 0.65(0.21;0.87) 0.46(0.24;0.63) 0.06(-0.35;0.44) 0.35(0.04;0.60)
Adj. PY 0.37(-0.00;0.65) 0.23(-0.32;0.67) 0.41(0.19;0.60) 0.01(-0.39;0.40) 0.29(-0.03;0.56)
Adj. PY, symptoms 0.38(0.00;0.66) 0.29(-0.26;0.70) 0.41(0.17;0.58) 0.02(-0.38;0.41) 0.29(-0.03;0.56)
1 n pairs MZ male = 28, DZ male = 15, MZ female = 66, DZ female = 25, OS = 39. PY= pack years
Table 4 Fit statistics from structural equation modelling
for VC.
-2LL df AIC Diff Chi-2 Diff df p
Unadjusted
Model 1 2827,767 343 2141,767
Model 2 vs. 1 2827,870 344 2139,870 0,103 1 0,748
Model 3 vs.2 2829,011 347 2135,011 1,141 3 0,767
Adj. PY
Model 1 2812,858 341 2130,858
Model 2 vs.1 2812,859 342 2128,859 0,001 1 0,976
Model 3 vs.2 2815,019 345 2125,019 2,161 3 0,540
Adj. PY, sympt.
Model 1 2805,169 339 2127,169
Model 2 vs.1 2805,215 340 2125,215 0,046 1 0,830
Model 3 vs.2 2809,601 343 2123,601 4,386 3 0,223
Models: 1) rg (genetic correlation) free for DZ opposite-sex twins, ACE
different for men and women. 3) rg fixed at 0.5 for DZ OS, ACE different for
men and women. 4) rg fixed at 0.5 for DZ OS, ACE same for men and women,
df = degrees of freedom, PY= pack years
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men and women. Variance is expressed in absolute numbers and is shown for unadjusted data (% pred), data adjusted for pack years (PY) and
data adjusted for pack years and respiratory symptoms (PY + SYM).
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lung function parameters for men and women. Since it
is known that genes influence smoking habits, we chose
to present results both with and without the adjustment
of pack years. Symptoms on the other hand can be a
part of COPD. Adjusting for symptoms give estimates of
heritability for lung function not associated with symp-
toms. The differing results for how much these covari-
ates influenced the three measures used in the current
study are not unreasonable as the measures represent
different aspects of lung function. Smoking induced
pathology is likely to be primarily seen in FEV1 and
DLco, while VC can remain, at least initially, essentially
normal. The approach of adjusting for covariates can
however underestimate heritability for the disease itself
particularly if they share genetic and environmental
effects in common. In women, smoking accounted for
some part of the genetic variance, while in men, it
accounted for parts of the shared environmental
variance. It has been suggested that due to differences
in how smoking has been socially accepted in men and
women, it is possible that men are more influenced by
cultural reasons for smoking than women [24]. Another
explanation to the apparent greater proportion in
g e n e t i cv a r i a n c ei nw o m e nc o u l db et h a tt h e r ei sa
reduction in absolute range of environmental variance
for smoking in women during the mid 1900’s, resulting
in a proportionate greater observed genetic variance.
Thus, genetic variance per se may not have changed, but
when seen in relation to environmental variance, it
appears to have increased [24].
Hence, smoking and respiratory symptoms could have
differential effects on the variance components of men
and women. The literature also provides examples of
sex-specific effects on different aspect of lung function
by genetic determination of physiological and hormonal
patterns, such as the connection between aerobic capa-
city and risk for development of COPD [25], the impact
of oestrogen on smoke toxins in the lung [26], and var-
iations in gas transfer over the menstrual cycle [27].
On the phenotypic level, sex differences in the rela-
tionship between smoking and lung function impair-
ment have been described in the literature, where
women smoke less but have more severe lung function
decline and more symptoms [3,8,9]. Two recent studies
[28,29] have suggested the presence gene-environment
interaction, i.e. that the effect of smoking on lung func-
tion (here FEV1) is dependent on the genotype of the
individual. Given our results, we suggest that there are
sex differences of importance to the genetic and envir-
onmental influence on lung disease. However, the num-
ber of twin pairs in the current study was insufficient to
evaluate possible interactions. Age is an important cov-
ariate in lung disease, but in the current study the num-
ber of participants prevented further modelling.
Conclusions
We have in a sample of twins with and without smoking
and respiratory symptoms, shown that not only environ-
ment but also genes determine the variability in VC,
FEV1 and DLco. Differences between men and women
were found in the size of the relative importance of
genes, but also in the type of genetic pattern (additive
vs. dominant). Adjustments of smoking and respiratory
symptoms had also differential effect on men and
women for FEV1 and DLco. Further studies on gene-
environment interaction are needed to fully understand
the sex differences in respiratory disease. The present
study highlights the importance of evaluating genetic
and environmental influence on lung function by sex,
and suggests that patients with lung diseases such as
COPD could benefit from interventions that are sex spe-
cific both on the genetic and environmental level.
Table 5 Fit statistics from structural equation modelling
for FEV1.
-2LL df AIC Diff Chi-2 Diff df p
Unadjusted
Model 1 2908,199 343 2222,199
Model 2 vs. 1 2908,199 344 2220,199 0,000 1 0,986
Model 3 vs. 2 2916,168 347 2222,168 7,969 3 0,047
Adj. PY
Model 1 2864,305 341 2182,305
Model 2 vs. 1 2864,305 342 2180,305 0,001 1 0,980
Model 3 vs. 2 2171,283 345 2181,283 6,978 3 0,073
Adj. PY, sympt.
Model 1 2845,428 339 2167,428
Model 2 vs. 1 2845,448 340 2165,448 0,021 1 0,885
Model 3 vs. 2 2853,815 343 2167,815 8,367 3 0,039
Models: 1) rg (genetic correlation) free for DZ opposite-sex twins, ACE
different for men and women. 3) rg fixed at 0.5 for DZ OS, ACE different for
men and women. 4) rg fixed at 0.5 for DZ OS, ACE same for men and women
df = degrees of freedom, PY= pack years
Table 6 Fit statistics from structural equation modelling
for DLco.
Men ACE -2LL df AIC
DLco: unadjusted 727,511 82 563,511
DLco: adj. PY 708,851 81 546,851
DLco: adj. PY, symptoms 703,134 80 543,134
Women ADE -2LL df AIC
DLco: unadjusted 1507,060 178 1151,060
DLco: adj. PY 1491,184 177 1137,184
DLco: adj. PY, symptoms 1490,454 176 1138,454
PY= pack years
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men and women. Variance is expressed as percentage of total variance and is shown for unadjusted data (% pred), data adjusted for pack
years (PY) and data adjusted for pack years and respiratory symptoms (PY + SYM).
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Specification of questions from the SALT questionnaire
1. Do you have recurrent periods of coughing?
If yes:
2. Do you regularly cough up phlegm?
Do you have or have you had:
3. Chronic bronchitis (bronchitis)
4. Emphysema
Chronic bronchitis was defined as:
Recurrent cough with phlegm production, and/or self
reported chronic bronchitis and/or self reported emphy-
sema (positive answers to questions 1+2 or 3 or 4).
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